20
Views
12
CrossRef citations to date
0
Altmetric
Articles

Potential Transmission of the Cytogenetic Effects of Cisplatin in the Male Germline Cells of Swiss Mice

Pages 352-359 | Published online: 18 Jul 2013

REFERENCES

  • Coleman CN, Williams CJ, Fluit A, Glastein EJ, Rosenberg SA, Kaplan HS. Haematologic neoplasia in patients treated for Hodgkin's disease. N Engl J Med 1977; 297: 1249–1252.
  • de Serres FJ, Matsushima T. Meeting report: Mutagenesis and carcinogenesis by nitropyrenes and cancer chemotherapeutics. Mutation Res 1986; 164: 3–8.
  • Pratt CB, Pui CH. Second tumors after treatment with anticancer drugs. In: The Toxicity of Anticancer Drug. eds. by Powis G, Hacker MP, New York: Pergamon Press, 1991; 28-43.
  • IARC. IARC Monographs on the evaluation of carcino-genic risks to humans: Genetic and related effects: An updat-ing of selected IARC Monographs, from vols. 1-42. IARC Scientific Publication, IARC, Lyon, France 1987; Suppl. 6: 178-181.
  • IARC. IARC Monographs on the evaluation of carcino-genic risks to humans. Some pharmaceutical drugs. IARC Scientific Publication, IARC, Lyon, France 1990; 50: 415.
  • Marselos M, Vainio H. Carcinogenic properties of phar-maceutical agents evaluated in the IARC Monographs programme. Carcinogenesis 1991; 12 (10): 1751–1766.
  • William CJ, Whitehouse JMA. Cis-platinum: A new anti-cancer agent. Br Med J 1979; 1: 1689–1691.
  • Rosenberg B. Fundamental studies with cisplatin. Cancer 1985; 55: 2303–2316.
  • Oliver RT. Testicular cancer. Curr Opin Oncol 1994; 6: 285–291.
  • Greene MH. Is cisplatin a human carcinogen? J Natl Cancer Inst 1992; 84: 306–312.
  • Kelland LR, McKeage MJ. Platinum drugs currently in clinical trial. Curr Opin Invest Drugs 1993; 2: 571–580.
  • Weiss RB, Christian MC. New cisplatin drugs in devel-opment. Drugs 1993; 46: 362–377.
  • Choudhury RC, Hasan A, Mahanty V. Effects of mer-curic chloride on mitotic, meiotic chromosomes and sperm in mice. Biol Zent BI 1995; 114: 369–377.
  • Evans EP, Breckon G, Ford CE. An air-drying method for meiotic preparation from mammalian testis. Cytogenetics 1964; 3: 289–294.
  • Wyrobek AJ, Bruce WR. Chemical induction of sperm abnormalities in mice. Proc Nat Acad Sci USA 1975; 72: 4425–4429.
  • Rathenberg R. Cytogenetic effects of cyclophosphamide on mouse spermatogonia. Humangenetik 1975; 29: 135–140.
  • Waters MD, Stack HF, Jackson MA, Bridges BA, Adler ID. The performance of short-term tests in identifying poten-tial germ cell mutagens: a qualitative and quantitative analysis. Mutation Res 1994; 341: 109–131.
  • Machemer L, Lorke D. Method for testing mutagenic effects of chemicals on spermatogonia of the Chinese ham-ster, results obtained with cyclophosphamide, saccharin and cyclamate. Arzneimittel-Forsch Drug Res 1975; 25: 1889–1896.
  • Schleiermacher E. The activity of alkylating agents. II. Histological and cytogenetic finding in spermatogenesis. In: Chemical Mutagenesis in Mammals and Man, Vogel F, Rohrborn G, Eds. Berlin, Heidelberg, New York: Springer-verlag, 1970: 317-341.
  • Sotomayor RE, Cumming RB. Induction of transloca-tions by cyclophosphamide in different germ cell stages of male mice: Cytological characterization and transmission. Mutation Res 1975; 27: 375–388.
  • Generoso WM, Cain KT, Huff SW, Gosslee DG. Heritable translocation test in mice. In: Chemical Mutagens Hollander A, de Serres FJ, Eds. New York: Plenum Press 1978; 5: 55–77.
  • witt KL, Bishop JB. Mutagenicity of anticancer drugs in mammalian germ cells. Mutation Res 1996; 355: 209–234.
  • Adler ID, El-Tarras A. Clastogenic effects of cis-diamminedichloroplatinum. I. Induction of chromosomal aberrations in somatic and germinal cells of mice. Mutation Res 1989; 211: 131–137.
  • Adler ID, El-Tarras A. Clastogenic effects of cis-diamminedichloroplatinum. II. Induction of chromosomal aberrations in primary spermatocytes and spermatogonial stem cells of mice. Mutation Res 1990; 243: 173–178.
  • Biswas T, Chakrabarti S. Germ cell cytotoxicity in tumour-bearing mouse subjected to single therapeutic dose of cis-diamminedichloroplatinum (II). Curr Sci 1993; 65: 82–84.
  • Meistrich ML, Finch M, da Cunha MF, Hacker U, Au WW. Damaging effects of fourteen chemotherapeutic drugs on mouse testis cells. Cancer Res 1982; 42: 122–131.
  • Allen JW, Poorman PA, Backer LC, Gibson JB, Westbrook-Collins B, Moses MJ. Synaptonemal complex dam-age as a measure of genotoxicity at meiosis. Cell Biol Toxicol 1988; 4: 487–494.
  • Backer LC, Gibson JB, Moses MJ, Allen JW. Synaptonemal complex damage in relation to meiotic chromo-some aberrations after exposure of male mice to cyclophos-phamide. Mutation Res 1988; 203: 317–330.
  • Preston RJ, Au W, Bender MA, et al. Mammalian in vivo and in vitro cytogenetic assays: A report of the U.S. EPA's Gene-Tox Program. Mutat Res 1981; 87: 143-188.
  • Sharma A. Environmental Chemical Mutagenesis. Perspective Report, Golden Jubilee Publication, Indian National Science Academy, New Delhi 1984; 6: 1–53
  • Choudhury RC, Misra S, Mishra MK. Genotoxic effects of phenyl mercuric acetate on somatic and germline cells of male Swiss mice in vivo. Biol Zent bl 1996; 115: 278–288.
  • Robbins WA. Cytogenetic damage measured in human sperm following cancer chemotherapy. Mutation Res 1996; 355: 235–252.
  • Jenderny J, Rohrborn G. Chromosome analysis of human sperm. Hum Genet 1987; 76: 385–388.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.